INTRODUCTION
============

Acute inflammation is the body's local response to any infection or injury [@B001] and is the first line of defense against infection or injury and involves the release of immune mediators and vasodilation in the area of infection [@B002]. The process of acute inflammation occurs within a short duration in response to infection or injury and after the immune response is evoked, it is generally restored [@B003], [@B004]. Clinically, endotoxin shock (e.g. sepsis or septic shock) occurs when acute inflammation persists for a prolonged period.

Toll-like receptors (TLRs) are a major recognition and signaling component of the mammalian host defense that activate nuclear factor kappa B (NF-κB), mitogen-activated protein (MAP) kinases, and interferon (IFN) response factor proteins [@B005], [@B006]. Nucleotide-binding oligomerization domain-like receptors (NLRs) are located in the cytosol and are stimulated by microbial inducers like bacterial toxins [@B007], [@B008]. The inflammasome complex assembly stimulates secretion of pro-inflammatory cytokines, such as interleukin (IL)-1β and 18 through activation and cleavage of caspase-1 [@B009]. In a recent study, two different mechanisms to activate NLRP3 inflammasome assembly have been identified. One is the early phase of inflammasome induced by TLR signaling through the TLR-signaling molecule IL-1 receptor-associated kinase (IRAK-1), a serine/threonine kinase. And another pathway is the late phase of acute inflammasome activation regulated by IRAK-2 and responses to activation of the NLRP3 signaling [@B010].

Mouse IRAK family members IRAK-1, 2, 3, and 4 are expressed in the liver, kidneys, and testis, where they play key roles in multiple signaling pathways involved in TLR signaling and pro-inflammatory cytokine secretion [@B011], [@B012]. IRAK proteins contain a proST domain, an N-terminal death domain (DD), a central conserved kinase domain, and a C-terminal domain [@B013]. IRAK-1 is phosphorylated by TLR4 signaling activated by the MyD88-IRAK-4 axis and functions in IL-1β signaling by recruiting the IκB kinase complex [@B014]. Phosphorylated IRAK-1 combines with tumor necrosis factor (TNF) receptorassociated factor 6 (TRAF6) to induce stimulation of NF-κB, c-Jun N-terminal kinase (JNK), and signal transducer and activator of transcription 3 (ATF3) [@B015], [@B016].

Corosolic acid (CA), a natural pentacyclic triterpenoid acid isolated from *Lagerstroemia speciosa* L. (Banaba), possesses antiatherosclerotic, antihyperlipidemic, antioxidant, anti-inflammatory, antidiabetic, antifungal, antiviral, and antineoplastic activities [@B017]-[@B024]. The effects of CA are thought to be mediated by peroxisome proliferator activator receptor (PPAR), mitogenactivated protein kinase, NF-κB, and other signal transduction factors [@B025]. However, the precise mechanisms underlying the effects of CA against acute inflammation remain unclear, hampering the development of effective drugs based on CA for clinical use. In the present study, CA was found to ameliorate acute inflammation by suppressing phosphorylation and transcription of IRAK-1 in mouse bone marrow-derived macrophages (BMDM).

RESULTS
=======

CA confers resistance to proinflammatory toxic shock
----------------------------------------------------

Macrophages play a pivotal role in the innate immune response to pathogen challenge. Because CA inhibits NF-kB signaling, we examined the hypothesis that CA might have a protective effect against septic shock by using an *in vivo* model system to evaluate responses to endogenous pathogen engagement. Survival was monitored for 10 days after cecal ligation and puncture (CLP) surgery was performed. Survival curves showed that the survival rate of the CLP group was significantly decreased in comparison with that of the sham and sham+CA mice groups (controls); however, the survival rates of the two control groups were not significantly different. Strikingly, on day 10, mortality was decreased by 50% in the CLP+CA mice group relative to the group that received no treatment in addition to CLP, indicating the potential of CA to prevent CLP-induced sepsis ([Fig. 1](#F001){ref-type="fig"}A). After CLP surgery, survival was correlated with serum levels of pro-inflammatory cytokine IL-1β ([Fig. 1](#F001){ref-type="fig"}B). After CA administration, serum IL-1β levels were significantly reduced in comparison with those of the group that received no treatment in addition to CLP. Taken together, these results suggest that CA reduces susceptibility to endotoxin shock in an *in vivo* model of sepsis.

![Effect of CA on mice subjected to cecal ligation and puncture (CLP) surgery and inflammasome assembly. (A) Survival of mice after CLP with or without CA (2 μg/kg). Mortality of Sham (n = 14), Sham+CA (n = 14), CLP (n = 14), and CLP+CA mice (n = 15) was monitored for 10 days after CLP surgery. (B) IL-1β secretion *in vivo*. Serum samples were collected 0, 6, and 12 h after surgery. The IL-1β concentration was measured by ELISA. The survival rate was estimated by the Kaplan-Meier method and compared by using the log-rank test. \*\*P ＜ 0.01. CLP versus CLP+CA, Sham, sham laparotomy; CLP, one puncture in the cecum; CLP+CA, one puncture in the cecum and CA injection.](BMB-49-276-g001){#F001}

CA regulates expression and phosphorylation of IRAK-1
-----------------------------------------------------

LPS-induced inflammatory responses stimulate proinflammatory cytokine secretion by increasing IRAK activity through phosphorylation [@B026]. Therefore, to measure the effect of CA on IL-1β secretion, enzyme-linked immunosorbent assays (ELISA) were performed to measure pro-inflammatory cytokine secretion from BMDMs. As shown in [Fig. 2](#F002){ref-type="fig"}A, IL-1β secretion was markedly increased after LPS treatment; however, LPS-stimulated IL-1β expression was significantly decreased after CA treatment. Because infection-induced IL-1β secretion in macrophages requires activation of the NLRP3-ASC inflammasome complex, we performed immunocytochemistry to localize NLRP3 and ASC. While the number of inflammasome complex-positive cells in the LPS group was increased, the population of inflammasome complex-positive cells in the CA and LPS+CA groups was low ([Fig. 2](#F002){ref-type="fig"}B), which suggested a weak inflammatory response to CA at the protein and mRNA levels. These results demonstrated that LPS treatment for a short duration induced inflammasome complex formation, which was inhibited by CA ([Fig. 2](#F002){ref-type="fig"}B). These data demonstrate that CA ameliorated acute inflammation by inhibiting inflammasome complex formation.

![CA regulates inflammasome assembly and IRAK-1 phosphorylation in BMDMs. BMDMs were isolated from mice and exposed to LPS (200 ng/mL) and/or CA (6 μM) for 30 min. (A) IL-1β secretion *in vitro*. BMDMs were treated with LPS and/or CA for 6 h and supernatants were collected. IL-1β secretion was measured by ELISA. (B) CA prevents inflammasome assembly. Immunocytochemistry for the inflammasome complex. BMDMs were treated with LPS and/or CA for 30 min, after which the treated cells were stained with fluorescence-labeled antibodies. Fluorescence was detected using confocal laser microscopy and LSM 3 EXCITER software. qPCR was used to measure mRNA levels of *NLRP3* (C), *IRAK1* (D), *IRAK2* (E), and *IRAK4* (F). (G) Protein samples were assessed by immunoblotting with the indicated antibodies. Graphs illustrate the mean ± SEM from 3 independent experiments. \*P ＜ 0.05, \*\*P ＜ 0.01 versus the relevant control group.](BMB-49-276-g002){#F002}

To investigate the involvement of molecular targets of CA in LPS-induced inflammation, after BMDMs were treated with LPS and CA for 30 min to induce acute inflammation, which expression levels of transcripts encoding TLR4 signaling proteins, including IRAK-1, IRAK-2, and IRAK-4 were measured by qPCR. The *NLRP3* and *IRAK-1* expression levels in the LPS-treated group were increased 2-fold in comparison with those in the control group. CA markedly decreased LPS-induced up-regulation of *NLRP3* and *IRAK-1* by approximately 40% ([Fig. 2](#F002){ref-type="fig"}C and D). In particular, *IRAK1* expression was increased rapidly following LPS treatment. *IRAK-2* and *IRAK-4* expression levels were unaffected after the 30-min LPS treatment ([Fig. 2](#F002){ref-type="fig"}E and F). These data indicated that CA may be involved in transcriptional regulation of IRAK-1. Next, to assess whether CA modulates IRAK phosphorylation, IRAK-1 phosphorylation level was detected by immunoblotting. Interestingly, LPS drastically reduced LPS-mediated IRAK-1 phosphorylation, but this effect was attenuated by CA. Based on this data, we inferred that CA regulates IRAK-1 phosphorylation. The level of NLRP3 protein, which was elevated by LPS, decreased after treatment with CA during acute inflammation ([Fig. 2](#F002){ref-type="fig"}G). This is the first study to demonstrate CA-induced inhibition of IRAK-1 phosphorylation in acute inflammation.

Effect of CA on LPS-mediated TLR4 signaling
-------------------------------------------

To further address the early-phase anti-inflammatory effects of CA, we investigated the dependence of the anti-inflammatory effect of CA on NF-κB signaling. Mouse BMDMs were incubated with the indicated concentrations of Bay11-7082 (an inhibitor of IκB-α) and IRAK inhibitor as an inhibitor of both IRAK-1and IRAK-4, followed by stimulation with LPS and/or CA for 30 min to induce inflammation ([Fig. 3](#F003){ref-type="fig"}). LPS treatment increased *NLRP3* expression by more than 2-fold in comparison with that of the control cells. The effect of LPS on *NLRP3* expression was attenuated by treatment with CA or the IRAK inhibitor, but not by Bay11-7082 treatment ([Fig. 3](#F003){ref-type="fig"}A). CA attenuated LPS-induced *IRAK-1* expression by approximately 75%, but Bay11-7082 and the IRAK inhibitor had no effect, suggesting that CA-induced inhibition of *IRAK-1* expression may independent of NF-κB signaling ([Fig. 3](#F003){ref-type="fig"}B). *IRAK-2* and *-4* expression levels were not affected by exposure to LPS or CA ([Fig. 3](#F003){ref-type="fig"}C and D).

![Relationship between CA and NF-kB signaling in acute inflammation. BMDMs were isolated from mice and exposed to LPS (200 ng/mL) and/or CA (6 μM), Bay11-7082 (10 μM), or an IRAK inhibitor (2.5 μM) for 30 min. qPCR was used to measure mRNA levels of *NLRP3* (A), *IRAK1* (B), *IRAK2* (C), and *IRAK4* (D). \*P ＜ 0.05, \*\*P ＜ 0.01 versus the relevant control group.](BMB-49-276-g003){#F003}

Anti-inflammatory effect of CA on acute inflammation
----------------------------------------------------

In order to further explore the anti-inflammatory effect of CA, mouse BMDMs were treated for 30 min with gentamicin (an antibiotic), ibuprofen (a nonsteroidal anti-inflammatory drug), or dexamethasone (a steroidal anti-inflammatory agent). LPS-induced expression of *NLRP3*, a target gene of NF-κB, was 2-fold greater than that of the control cells; however, LPS-induced *NLRP3* expression was decreased by approximately 30% after CA treatment and by approximately 40% after treatment with gentamicin and ibuprofen. Dexamethasone treatment did not affect *NLRP3* expression ([Fig. 4](#F004){ref-type="fig"}A). LPS up-regulated expression of *IL-1β*, another NF-κB target, by 25-fold; however, this effect was decreased by approximately 40% following treatment with CA and ibuprofen, by 50% following treatment with dexamethasone, and by more than 90% following treatment with gentamicin ([Fig. 4](#F004){ref-type="fig"}B). These findings demonstrate the therapeutic potential of CA as an anti-inflammatory drug.

![Effect of CA on LPS-mediated inflammation. (A-B) Effect of CA as an anti-inflammatory drug. BMDMs were isolated from mice and exposed to LPS (200 ng/mL) and/or gentamicin (10 μM), dexamethasone (10 μM), ibuprofen (10 μM), or CA (6 μM) for 30 min. qPCR was used to measure mRNA levels of *NLRP3* and IL-1β. (C) Schematic summary of the role of CA in regulating early-phage inflammation. Graphs illustrate the mean ± SEM from 3 independent experiments. \*P ＜ 0.05, \*\*P ＜ 0.01, \*\*\*P ＜ 0.001 versus the relevant control group.](BMB-49-276-g004){#F004}

DISCUSSION
==========

In the present study, we describe the mechanism underlying NF-κB-independent regulation of acute inflammation by CA. We investigated new targets of CA in the context of LPS-induced acute inflammation. Although the anti-inflammatory effect of CA has been reported [@B017], the cellular mechanism underlying this effect has not been fully elucidated. Our results elucidated the mechanism underlying CA-mediated regulation of acute inflammation *in vitro* and *in vivo* (Fig. 4C).

LPS stimulates the production of cytokines and other inflammatory mediators by inflammatory cells, and is generally regarded as a key initiating factor in the pathogenesis of septic shock. Studies have demonstrated that LPS induces cellular responses by activating signaling molecules belonging to the TLR family [@B027]. Here, we treated BMDMs with LPS for 30 min to induce acute inflammation. Similar to the results of a previous study [@B020], the inflammatory cytokine expression of the CA-treated group was significantly attenuated in comparison with that of the group treated with LPS alone. In the priming stimulation to induce NLRP3 inflammasome activation, TLR signaling connects to NLRP3 sequentially bypassing NF-κB signaling [@B010], [@B028]. LPS-dependent TLR activation is directly implicated in acute NLRP3 inflammasome activation through the MyD88-IRAK4-IRAK1 signaling network [@B029]. The early priming inflammasome assembly differs from the late primingmediated signaling. Therefore, IRAK-1 may play a pivotal role in acute inflammation appears to control inflammasome complex assembly and activation [@B030]. We also showed that LPS-induced acute inflammation increased expression of IRAK-1, but not IRAK-2. Although the total protein level of IRAK-1 was decreased, LPS increased IRAK-1 phosphorylation, which was attenuated by CA treatment. Furthermore, immunocytochemical staining of the inflammasome complex assembly revealed that LPS-induced complex formation was inhibited by CA treatment in the early period of inflammation. While a previous report showed that IRAK-1 phosphorylation stimulated inflammatory cytokine release by inducing inflammasome complex assembly [@B010], our results suggested that CA abolished inflammasome complex formation through inhibition of LPS-induced IRAK-1 phosphorylation. The precise mechanism underlying the regulation of inflammasome complex formation by IRAK-1 phosphorylation remains to be elucidated.

Based on previous studies that demonstrated different regulatory scenarios for chronic and acute inflammation [@B030], we sought to determine whether the anti-inflammatory effects of CA were mediated via an NF-κB-dependent pathway. In a chronic inflammatory condition, exposure of LPS-pretreated BMDMs to CA down-regulated expression of NF-κB target genes NLRP3 and IL-1β. Similar results were observed when cells were treated with LPS and Bay11-7082, an NF-κB inhibitor, indicating that the effects of CA were mediated by NF-κB signaling. Similar results were observed upon treatment with an inhibitor of IRAK, which is an upstream signaling molecule of LPS-induced activation of TLR4, which ultimately activates NF-κB. According to the available literature, acute inflammation occurs independently of NF-κB. However, based on our findings, specifically data on IRAK-2 and NLRP3 expression after treatment with Bay11-7082 and IRAK inhibitors in cells treated with LPS for 30 min, showed that acute inflammatory reactions are not completely NF-κB-independent. Rather, NF-κB has a role in the regulation of target gene expression during acute inflammation. Importantly, IRAK-1 expression did not decrease after treatment with Bay11-7082 or an IRAK inhibitor, implicating the role of another transcription factor in LPS-induced acute inflammation. CA inhibited this unknown transcription factor, this regulating IRAK-1 gene expression. In TLR signaling, IRAK-1 is phosphorylated by IRAK-4 through the MyD88 pathway [@B031]. Here, we did not clearly address how the phosphorylation of IRAK-1 changes without IRAK-4 being affected. And we need to investigate the process of IRAK-1 phosphorylation modulation by CA as a further study.

Because CA regulated IRAK-1 activity in an acute inflammation condition known to be NF-κB-independent, we hypothesized inhibitory effects of CA on endotoxin shock response or septic shock. Indeed, the administration of CA had a significant protective effect against CLP-induced septic animal model. And also IL-1β secretion levels at 6 and 12 h after CLP surgery were reduced in CLP plus CA group compared to CLP group. These findings suggest that CA reduces mortality in polymicrobial sepsis through inhibition of IRAK-1 phosphorylation.

In conclusion, our study indicates that the CA plays a role in inhibitory effect on an acute inflammation. Furthermore, we identified a novel pathway through which CA regulates IRAK-1 phosphorylation via an NF-κB-independent pathway. These results propose the possibility of using CA as a medication for acute inflammatory diseases, such as sepsis and endotoxin shock.

MATERIALS AND METHODS
=====================

Chemicals and reagents
----------------------

Fetal bovine serum (FBS) and Dulbecco's modified eagle's medium (DMEM) media for cell culture were purchased from Hyclone. LPS (lipopolysaccharide), Corosolic acid (PubChem CID : 6918774), Bay11-7082 (PubChem CID : 24891842), and Interleukin-1 Receptor-Associated-kinase 1/4 inhibitor (PubChem CID : 11983295) were purchased from Sigma-Aldrich and dissolved in the recommended solvents. Antibodies against IRAK-1 and IRAK-4 were purchased from Cell Signaling Technology; anti-IRAK-2 and ASC were purchased from Novus Biologicals, Inc.; phospho-IRAK-1 was purchased from Bioworld Technology; β-actin was purchased from Santa Cruz Biotechnology.

Animal studies
--------------

8-week-old male C57BL/6 mice (Jung-Ang Experimental Animals, Seoul, Republic of Korea) were used in the experiment. All animal experiments were performed in accordance with the rules and regulations of the Institutional Animal Use and Care Committee (IAUCC), Keimyung University School of Medicine (KM-2012-24R).

Isolation and culture of primary mouse bone marrow-derived macrophages
----------------------------------------------------------------------

Bone marrow-derived macrophages (BMDM) were isolated from C57BL/6 as previously described [@B032]. Briefly, the C57BL/6 mice were sacrificed by cervical dislocation and femurs were dissected free of adherent tissue. Mouse bone marrow cells were flushed from femurs and tibias. Separated bone marrow cells were cultured in DMEM media, containing 10% FBS, 1% penicillin/streptomycin, and 20% L929 cells conditioning media for 7 days to differentiate into BMDM.

Real-time PCR
-------------

Total RNA was isolated from mouse primary hepatocytes and livers using the Trizol method (Invitrogen). cDNA was synthesized using a SuperScript III First-strand cDNA synthesis kit (Invitrogen) and used for qPCR with Roche Lightcycler^Ⓡ^ Real-Time PCR systems (Roche Applied Science, Indianapolis, IN, USA). All data were normalized to ribosomal L32 expression. The following primer sets for mouse were used: mouse NF-κB, forward, 5'-GTGCAGTGTCTTGGCTTTCT-3'; reverse, 5'-CGGAGGGACAGCAGTAACAAC-3'; mouse IL-1β, forward, 5'-ATG AGAGCATCCAGCTTCAA-3', reverse, 5'-TGAAGGAAAAGA AGGTGCTC-3'; mouse NLRP3, forward, 5'-ATTACCCGCCC GAGAAAGG-3', reverse, 5'-CATGAGTGTGGCTAGATCCA AG-3'; mouse ASC, forward, 5'-ACTATCTGGAGTCGTATGG CTT-3', reverse, 5'-CTGGTCCACAAAGT GTCCTGT-3'; mouse IRAK-1, forward, 5'-CCTTCAGAGAGGCTAGCTGTACC-3', reverse, 5'-ACTTTGACCTCTGAGTCTGAGGG-3', mouse IRAK-2, forward, 5'-AGC ACAGCCATCCACCAG-3', reverse, 5'-GATCTCAATTTTCCATGAAGTCT-3'; IRAK-4, forward, 5'-CATACGCAACCTTAATGTGGGG-3', reverse, 5'-GGAACTGAT TGTATCTGTCGTCG-3'; mouse L32, forward, 5'-ACATTTGCCCTGAATGTGGT-3'; reverse, 5'-ATCCTCTTGCCCTGATCCTT-3'.

Western blot analyses
---------------------

Mouse BMDM were isolated and processed according to a method described previously [@B033]. The membranes were probed with indicated antibodies, and then developed using an enhanced chemiluminescent Western blot detection kit (Amersham Bioscience, Piscataway, NJ, USA). The intensities of bands were calculated using ImageJ, verifying for non-saturation and subtracting background. Values are expressed as the integrals (target area density) of each band (normalized to total indicated protein band).

Immunocytochemistry analysis
----------------------------

8-chamber culture dish was subjected to either control medium or LPS and/or CA contained medium were fixed in 4% buffered paraformaldehyde in PBS. Fixed cells were permeabilized and incubated in blocking solution (1% BSA and 0.1% Triton-X in PBS) at room temperature for 1 h before overnight incubation at 4℃ with primary antibodies for NLRP3 and ASC. Following incubation with primary antibodies, the cells were incubated with the appropriate Alexa Fluor-conjugated secondary antibodies (Life Technologies) for 1 h at room temperature. Following secondary antibody incubation, chamber slides were sealed with fluorescent mounting medium containing DAPI (molecular probes) on glass slides. Images were acquired using a confocal laser scanning microscopy (Carl Zeiss).

Cecal ligation and puncture model
---------------------------------

Cecal ligation and puncture (CLP) surgery was used to induce acute septic peritonitis [@B034]. Blood samples were taken from the infraorbital plexus after subcutaneous injections with CA. The blood was spun down for 10 min in a centrifuge at 1,000 × g and 4℃ after drawing. The serum was stored at −80℃ until it was assayed. Animal survival data were evaluated by the Kaplan--Meier survival analysis and compared by using the log-rank test. A probability value of 0.01 or less was considered statistically significant.

IL-1β ELISA assay
-----------------

BMDMs were cultured and stimulated with LPS and/or CA supernatants collected after 6 h. The release of IL-1β was analyzed by ELISA (R&D Systems, Minneapolis, MN, USA) according to the manufacturer's instruction.

Statistical analysis
--------------------

Results are presented as mean ± standard deviation of at least three separate experiments. Differences between groups were detected by one-way analysis of variance or a paired Student's *t*-test. Differences were considered statistically significant at P ＜ 0.05.
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